UBS ASSET MANAGEMENT AMERICAS LLC - SAREPTA THERAPEUTICS INC ownership

SAREPTA THERAPEUTICS INC's ticker is SRPT and the CUSIP is 803607100. A total of 373 filers reported holding SAREPTA THERAPEUTICS INC in Q3 2022. The put-call ratio across all filers is 0.81 and the average weighting 0.2%.

Quarter-by-quarter ownership
UBS ASSET MANAGEMENT AMERICAS LLC ownership history of SAREPTA THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$19,538,482
-9.5%
161,182
+2.9%
0.01%
-10.0%
Q2 2023$21,596,4440.0%156,6890.0%0.01%0.0%
Q1 2023$21,596,444
+37.4%
156,689
+29.2%
0.01%
+25.0%
Q4 2022$15,720,777
-99.9%
121,321
+1.0%
0.01%
+14.3%
Q3 2022$13,272,205,000
+27.8%
120,067
-13.3%
0.01%
+40.0%
Q2 2022$10,382,485,000
-3.4%
138,507
+0.7%
0.01%0.0%
Q1 2022$10,745,014,000
-27.6%
137,545
-16.5%
0.01%
-16.7%
Q4 2021$14,835,378,000
+57.1%
164,746
+61.4%
0.01%
+50.0%
Q3 2021$9,441,376,000
+8.7%
102,091
-8.6%
0.00%0.0%
Q2 2021$8,685,348,000
-43.2%
111,723
-45.5%
0.00%
-42.9%
Q1 2021$15,281,783,000
-78.0%
205,042
-49.6%
0.01%
-78.1%
Q4 2020$69,313,563,000
+24.7%
406,555
+2.7%
0.03%
+6.7%
Q3 2020$55,593,286,000
-12.3%
395,879
+0.1%
0.03%
-23.1%
Q2 2020$63,420,723,000
+42.2%
395,539
-13.2%
0.04%
+21.9%
Q1 2020$44,592,126,000
-23.5%
455,859
+1.0%
0.03%
-11.1%
Q4 2019$58,258,075,000
+96.8%
451,473
+14.8%
0.04%
+80.0%
Q3 2019$29,608,367,000
-34.3%
393,101
+32.6%
0.02%
-37.5%
Q2 2019$45,063,050,000
+48.7%
296,565
+16.6%
0.03%
+45.5%
Q1 2019$30,310,254,000
+13.7%
254,302
+4.1%
0.02%
-4.3%
Q4 2018$26,669,518,000
-26.0%
244,383
+9.5%
0.02%
-14.8%
Q3 2018$36,036,272,000223,1210.03%
Other shareholders
SAREPTA THERAPEUTICS INC shareholders Q3 2022
NameSharesValueWeighting ↓
Perceptive Advisors 2,878,979$69,182,0007.27%
Eventide Asset Management 259,100$6,226,0000.97%
GLADE BROOK CAPITAL PARTNERS LLC 251,000$6,032,0000.93%
IMS Capital Management 32,215$774,0000.91%
Perceptive Advisors 350,000$8,413,0000.88%
Benchmark Capital Advisors 34,900$839,0000.58%
BECK CAPITAL MANAGEMENT, LLC 24,744$636,0000.49%
SABBY MANAGEMENT, LLC 352,100$8,461,0000.47%
Hatteras Alternative Mutual Funds, LLC 39,404$947,0000.46%
Potomac Capital Management, Inc. 22,100$531,0000.45%
View complete list of SAREPTA THERAPEUTICS INC shareholders